Kinase Inhibitor Market, By Product (Angiogenesis Inhibitor, mTOR Inhibitor, BRAF & MEK Inhibitor and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI467021 | Publish Date: August 2023 | No. of Pages: 192

Global Kinase Inhibitor Market Overview

The rising prevalence of cancer has been one of the major threats to the healthcare industry. It is accounted to be the second leading cause of mortality, worldwide. With the increasing life span and high life expectancy, the population of elderly people is expected to increase in future. Accumulation of genetic mutations with rising lifespan is expected to increase the chances of people developing cancer, thereby increasing the prevalence of cancer. Kinase inhibitor blocks the action of one or more protein kinases and add phosphate group to protein, and can modulate its function. Phosphorylation regulates many biological processes and kinase inhibitor can used to treat disease which are serious diseases like cancer due to its hyperactive protein kinases. These enzymes selectively block the action of other enzymes. The Kinase Inhibitor Market accounted for US$ 42.5 billion in 2020 and is estimated to be US$ 80.2 billion by 2030 and is anticipated to register a CAGR of 6.6%.

Impact of Covid-19 pandemic on market

Number of patients suffering from cancer is rising day by day. Due to lockdown the clinical trials were stopped and research labs were also affected during Covid-19. This report will quantify the impact of this pandemic on the diagnostics market.

Global Kinase Inhibitor Market Dynamics

Awareness about Kinase inhibitor

Awareness about kinase inhibitor and surge in product approvals are the major driving factors for this market. Investment from pharmaceutical companies also propel the market growth.

Increase in cancer patients

Increase in cancer patients worldwide triggers the market growth of kinase inhibitor and more research and development in this field also boost the market.

However, cost of treatment and lack of funds might hamper growth of the global market to a certain extent.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Kinase Inhibitor Market Segmentation

                                                                 

The global kinase inhibitor market is segmented based on product, distribution channel, and region.

On the basis of product, the global kinase inhibitor market is segmented into Angiogenesis Inhibitor, mTOR Inhibitor, BRAF & MEK Inhibitor and Others. Based on distribution channel, the target market is segmented into Hospital Pharmacies, Online Pharmacies and Others.

Regional Insights:

                                                                   

On region the global kinase inhibitor market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is considered dominating during the forecast period due to availability of all major key players in the region, awareness about new drugs for treatment, advancement in technologies and prevalence of cases in U.S. Europe is second dominating region in the market of kinase inhibitor.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2030

Market Segmentation

By Product- Angiogenesis Inhibitor, mTOR Inhibitor, BRAF & MEK Inhibitor and Others.

By Distribution Channel– Hospital Pharmacies, Online Pharmacies and Others.

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global kinase inhibitor market report based on product, distribution channel, and region.

                                                         

Global kinase inhibitor market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
      • Rest of Middle East & Africa

Global Kinase Inhibitor Market Key Players

The key players operating in the global kinase inhibitor market includes Incyte Corporation, Glaxo SmithKline, AstraZeneca, Eisai Co., Ltd., Bristol-Myers Squibb, Bayer AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Eisai Co., Ltd., Johnson & Johnson and F. Hoffmann-La Roche Ltd. Companies are continuously rising the production and supply of drugs to grow the market of kinase inhibitor.

Global Kinase Inhibitor Market Company Profile

  • F. Hoffmann-La Roche Ltd
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Incyte Corporation
  • Glaxo SmithKline
  • AstraZeneca, Eisai Co., Ltd.
  • Bristol-Myers Squibb
  • Bayer AG
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Boehringer Ingelheim GmbH
  • Eisai Co., Ltd.
  • Johnson & Johnson

Global Kinase Inhibitor Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Kinase Inhibitor Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product
      • Market Snippet, By Distribution channel
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Kinase Inhibitor Market , By Product, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Angiogenesis Inhibitor
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • mTOR Inhibitor
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • BRAF & MEK Inhibitor
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Kinase Inhibitor Market  , By Distribution Channel, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Online Pharmacies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Kinase Inhibitor Market  , By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Distribution channel, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Distribution channel, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Distribution channel, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Distribution channel, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Distribution channel, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  9. Company Profiles
  • F. Hoffmann-La Roche Ltd
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Incyte Corporation
  • Glaxo SmithKline
  • AstraZeneca, Eisai Co., Ltd.
  • Bristol-Myers Squibb
  • Bayer AG
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Boehringer Ingelheim GmbH
  • Eisai Co., Ltd.
  • Johnson & Johnson
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The global kinase inhibitor market is segmented based on product, distribution channel, and region.

Awareness about new drugs for treatment, advancement in technologies and prevalence of cases are the major growing factor

North America is considered dominating during the forecast period due to availability of all major key players in the region, awareness about new drugs for treatment, advancement in technologies and prevalence of cases in U.S. Europe is second dominating region in the market of kinase inhibitor.

The key players operating in the global kinase inhibitor market includes Incyte Corporation, Glaxo SmithKline, AstraZeneca, Eisai Co., Ltd., Bristol-Myers Squibb, Bayer AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Eisai Co., Ltd., Johnson & Johnson and F. Hoffmann-La Roche Ltd.

Side effects of thde treatment is the major restrain for this kinase inhibitor market.